Clinical Trial Update: Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating TJO-087 for moderate to severe dry eye disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• TJO-087

Snippet

Sponsor: Taejoon Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndrome | Phase 3 | Status: UNKNOWN